OMC
CEROW

Old Mission Capital’s CERo Therapeutics Warrants CEROW Stock Holding History

Old Mission Capital’s Portfolio CEROW Stock Details CEROW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-10,097
Closed -$435 – 1750
2022
Q4 		$435 Buy
+10,097
New +$531 ﹤0.01% 1401

Other funds holding CEROW

MP
Mangrove Partners Greenwich, Connecticut $1.24B AUM 41.74% 1-Year Est. Return
SCM
Segantii Capital Management Hong Kong $1.54B AUM 16.73% 1-Year Est. Return
PC
Periscope Capital Toronto, Ontario, Canada $902M AUM 6.27% 1-Year Est. Return
MI
MMCAP International Grand Cayman, Cayman Islands $1.16B AUM 76.63% 1-Year Est. Return
SCM
Shaolin Capital Management Miami, Florida $2.71B AUM 64.57% 1-Year Est. Return
CF
Cantor Fitzgerald New York $6.78B AUM 28.97% 1-Year Est. Return
HCM
Highbridge Capital Management New York $3.09B AUM 31.21% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 26.7% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.02% 1-Year Est. Return
SCM
Saba Capital Management New York $3.62B AUM 12.96% 1-Year Est. Return

Old Mission Capital's CEROW Position: Q1 2023 in Review

Old Mission Capital sold out of CERo Therapeutics Warrants (CEROW) in Q1 2023, closing a stake of 10,097 shares — an estimated $435 sold.

Old Mission Capital first reported a position in CEROW in Q4 2022 and held it in 1 quarter. The position peaked at $435 in Q4 2022. 46 funds tracked by Wall St. Rank hold CEROW as of Q1 2023.

  • Old Mission Capital reported no remaining CERo Therapeutics Warrants position as of Q1 2023 after selling out during the quarter.
  • Old Mission Capital sold 10,097 CERo Therapeutics Warrants shares in Q1 2023, an estimated $435.
  • Old Mission Capital first reported a position in CERo Therapeutics Warrants in Q4 2022 and held it in 1 quarter.
  • Old Mission Capital's CERo Therapeutics Warrants position peaked at $435 in Q4 2022.
  • 46 funds tracked by Wall St. Rank held CERo Therapeutics Warrants as of Q1 2023.

Based on Old Mission Capital's 13F filing for Q1 2023, filed 12 May 2023.